We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

143 hedge funds and large institutions have $651M invested in Immunogen Inc in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $1.8M

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

6% less funds holding

Funds holding: 152143 (-9)

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

38% less capital invested

Capital invested by funds: $1.05B → $651M (-$402M)

Holders
143
Holders Change
-9
Holders Change %
-5.92%
% of All Funds
3.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
54
Reduced
34
Closed
26
Calls
$5.14M
Puts
$1.8M
Net Calls
+$3.34M
Net Calls Change
+$2.91M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$2.19M -$315K -37,241 -13%
NC
27
Nexthera Capital
New York
$1.94M +$1.93M +228,000 New
GC
28
Guggenheim Capital
Illinois
$1.94M +$406K +47,941 +27%
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$1.93M +$1.62M +191,200 +551%
CS
30
Candriam SCA
Luxembourg
$1.76M -$255K -30,100 -13%
Natixis Advisors
31
Natixis Advisors
Massachusetts
$1.6M +$282K +33,377 +22%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$1.56M +$194K +22,905 +14%
Prudential Financial
33
Prudential Financial
New Jersey
$1.46M -$2.78M -328,800 -66%
LK
34
Lumbard & Kellner
New Hampshire
$1.43M -$5.71K -675 -0.4%
Citigroup
35
Citigroup
New York
$1.42M +$477K +56,324 +51%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$1.39M +$1M +118,307 +264%
Swiss National Bank
37
Swiss National Bank
Switzerland
$1.29M +$223K +26,400 +20%
AllianceBernstein
38
AllianceBernstein
Tennessee
$1.24M -$2.37K -280 -0.2%
TA
39
Teachers Advisors
New York
$1.1M
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.09M -$66K -7,800 -6%
PP
41
PDT Partners
New York
$1.09M +$9.31K +1,100 +0.9%
CCMH
42
Cornerstone Capital Management Holdings
New York
$1.08M -$849K -100,403 -44%
TFCP
43
Twin Focus Capital Partners
Massachusetts
$965K
CS
44
Credit Suisse
Switzerland
$944K +$491K +58,008 +110%
AA
45
ALPS Advisors
Colorado
$834K -$141K -16,680 -15%
BG
46
BlackRock Group
United Kingdom
$821K +$80.3K +9,496 +11%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$801K +$1.95K +230 +0.2%
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$797K
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$778K -$4.52M -534,832 -85%
PIM
50
Platinum Investment Management
Australia
$771K

IMGN Hedge Fund Activity: Q1 2016 in Review

143 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2016, worth a combined $651M — down 38% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of IMGN and 19 opened new positions — a net loss of 7 holders — while 34 trimmed existing stakes and 54 added.

The largest buyer was Vanguard Group, adding an estimated $2.74M. The largest seller was Fidelity Investments, cutting an estimated $4.76M.

  • 143 institutional investors held Immunogen Inc (IMGN) as of Q1 2016, down from 152 in Q4 2015.
  • Funds reported $651M of Immunogen Inc stock for Q1 2016, down 38% quarter-over-quarter.
  • 19 funds opened new Immunogen Inc positions in Q1 2016 and 26 closed out, a net change of -7 holders.
  • The largest Immunogen Inc buyer in Q1 2016 was Vanguard Group, an estimated $2.74M added.
  • The largest Immunogen Inc seller in Q1 2016 was Fidelity Investments, an estimated $4.76M sold.

Based on aggregated 13F filings for Q1 2016.